Showing results (501-510 of 1,408) with videos related to

Sort By:
Pageof 141
The American Journal of Medicine|November 1, 1980
Pulmonary alveolar proteinosis in two siblings with decreased immunoglobulin AJ R Webster, H Battifora, C Furey, et al.
Clinical Science (London, England : 1979)|February 1, 1995
Nitric oxide synthase activity is increased in patients with sepsis syndromeH F Goode, P D Howdle, B E Walker, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1993
Poor response to oral ciprofloxacin in the treatment of peritonitis in patients on intermittent peritoneal dialysisN M Waite, M D Johnson, N R Webster, et al.
Free Radical Biology & Medicine|January 1, 1996
Regulation of nitric oxide synthase activity in cultured human endothelial cells: effect of antioxidantsH F Galley, B E Walker, P D Howdle, et al.
Australian Veterinary Journal|October 2, 2008
Financial modelling of the potential cost of ovine Johne's disease and the benefit of vaccinating sheep flocks in southern New South WalesR D Bush, P A Windsor, J A Toribio, et al.
Oecologia|June 28, 2008
Drought-herbivory interaction disrupts competitive displacement of native plants by Microstegium vimineum, 10-year resultsChristopher R Webster, Janet H Rock, Robert E Froese, et al.
Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association|June 13, 2000
Ultrasonographic appearance and clinical findings in 14 dogs with gallbladder mucoceleJ G Besso, R H Wrigley, J M Gliatto, et al.
Critical Care Medicine|January 25, 2003
Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patientsPeter R Lowe, Helen F Galley, Ashraf Abdel-Fattah, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 23, 2011
Image-guided radiotherapy for rectal cancer: a systematic reviewS Gwynne, R Webster, R Adams, et al.
Critical Care Medicine|February 7, 2001
Phase II multicenter clinical study of the platelet-activating factor receptor antagonist BB-882 in the treatment of sepsisJ L Vincent, H Spapen, J Bakker, et al.
Pageof 141